Cold treatment to prevent nerve pain from weekly paclitaxel
Part of Cancer, Skin clinical trials.
This trial tests whether cryotherapy (cooling the hands/feet during chemo) can prevent or lessen nerve pain caused by paclitaxel in people with early breast cancer. It may help you stay more comfortable and function better during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have early-stage breast cancer and are scheduled to receive weekly paclitaxel (a chemotherapy drug) for 9 or 12 doses.
- You are planned to receive paclitaxel 80 mg/m² over about 1 hour, once per week.
- Your general ability to do daily activities is good (performance status 0–1).
- You do not already have nerve damage in the arms or legs (sensory or motor neuropathy).
- You do not have moderate or severe nerve pain symptoms or swelling in a limb (grade 2 or higher).
- You do not have Raynaud’s symptoms or poor blood flow to the arms/legs (peripheral arterial ischemia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether wearing cold gloves and socks during paclitaxel chemotherapy can prevent or reduce nerve damage in the hands and feet, a common side effect. If you are getting weekly paclitaxel for breast cancer, this might help keep your hands and feet more comfortable.
This trial tests if wearing special cooling gloves and socks during chemotherapy can help prevent nerve damage, tingling, or numbness in your hands and feet. It is for people with breast or gynecologic cancer who are starting certain types of chemo that can cause these side effects.
This study tests a cooling device (HILOTERM) worn on the hands and feet to try to prevent nerve damage (peripheral neuropathy) from paclitaxel chemotherapy in women with breast cancer after surgery.
This trial tests whether wearing tight surgical gloves during paclitaxel chemotherapy can prevent nerve damage (neuropathy) in the hands. It's for people with stage II or III breast cancer who are about to start paclitaxel treatment for at least 12 weeks.
This trial tests whether acupuncture and compression therapy can prevent nerve damage caused by taxane chemotherapy in early-stage breast cancer. It aims to reduce numbness, tingling, or pain in the hands and feet.
This trial tests if hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can reduce nerve pain caused by the chemotherapy drug nab-paclitaxel in breast cancer patients. It may help women who have finished chemo and are still dealing with numbness, tingling, or pain in their hands or feet.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.